MENU
LPCN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Lipocine (LPCN) Ownership - Who owns Lipocine?
Industry: @Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
675 Arapeen Drive
Phone
+1 801 994-7383
Employees
17
Web
https://www.lipocine.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
27.86M
P/E Ratio
N/A
Total Cash
10
Projected Growth
N/A
Total Debt
1.48M
Revenue
N/A
Risk (Beta)
1.65
Dividend Yield
N/A
Total Cash/Share
0.00
Total Debt/Equity
N/A
Revenue/Share
1.49 USD as % of share price
Fundamentals
LPCN
Capitalization
27.9M
P/E Ratio
N/A
Risk (Beta)
1.65
Dividend Yield
N/A
Total Cash
10
Total Cash/Share
0.00
Total Debt
1.48M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.49%
Revenue
N/A
ROE
N/A
Book Value
24M
P/B Ratio
1.46
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
8.86K
Current Ratio
16.99
Current Revenue Per Employee
448069.06
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
-479.60
Revenue To Assets
N/A
Shares Held By Institutions
5.7M
Shares Outstanding - Current
5.35M
Total Liabilities
1.49M
Total Volume MTD
N/A
Value
N/A
Gain YTD
86.738
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of pharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
675 Arapeen Drive
Phone
+1 801 994-7383
Employees
17
Web
https://www.lipocine.com